NO178149C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 7-tetrahydro-naftyridin-6-fluor-1,4-dihydro-4-okso-kinolin-3-karboksylsyrer - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive 7-tetrahydro-naftyridin-6-fluor-1,4-dihydro-4-okso-kinolin-3-karboksylsyrerInfo
- Publication number
- NO178149C NO178149C NO893305A NO893305A NO178149C NO 178149 C NO178149 C NO 178149C NO 893305 A NO893305 A NO 893305A NO 893305 A NO893305 A NO 893305A NO 178149 C NO178149 C NO 178149C
- Authority
- NO
- Norway
- Prior art keywords
- fluoro
- carboxylic acids
- naphthyridine
- tetrahydro
- quinoline
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1987/003412 WO1989005643A1 (fr) | 1987-12-18 | 1987-12-18 | Acides carboxyliques de quinoline a substitution heterocyclique |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO893305D0 NO893305D0 (no) | 1989-08-17 |
| NO893305L NO893305L (no) | 1989-10-17 |
| NO178149B NO178149B (no) | 1995-10-23 |
| NO178149C true NO178149C (no) | 1996-01-31 |
Family
ID=22202722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO893305A NO178149C (no) | 1987-12-18 | 1989-08-17 | Analogifremgangsmåte for fremstilling av terapeutisk aktive 7-tetrahydro-naftyridin-6-fluor-1,4-dihydro-4-okso-kinolin-3-karboksylsyrer |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5037834A (fr) |
| EP (1) | EP0321191B1 (fr) |
| JP (1) | JPH0725757B2 (fr) |
| KR (1) | KR900008568B1 (fr) |
| AT (1) | ATE113599T1 (fr) |
| AU (1) | AU600188B2 (fr) |
| DE (1) | DE3852010T2 (fr) |
| DK (1) | DK699788A (fr) |
| ES (1) | ES2061695T3 (fr) |
| FI (1) | FI90239C (fr) |
| IE (1) | IE65732B1 (fr) |
| IL (1) | IL88664A (fr) |
| MY (1) | MY104072A (fr) |
| NO (1) | NO178149C (fr) |
| NZ (1) | NZ227357A (fr) |
| PT (1) | PT89222B (fr) |
| WO (1) | WO1989005643A1 (fr) |
| ZA (1) | ZA889395B (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0251308B1 (fr) * | 1986-07-04 | 1990-11-22 | Chemie Linz Gesellschaft m.b.H. | Dérivés de l'acide 4-quinolone-3-carboxylique, leur procédé de synthèse et préparations pharmaceutiques les contenant |
| ES2074047T3 (es) * | 1987-08-14 | 1995-09-01 | Asahi Glass Co Ltd | Compuestos de benzoilo fluorados. |
| US5093515A (en) * | 1987-08-14 | 1992-03-03 | Asahi Glass Company Ltd. | Fluorinated benzoyl compounds |
| US5214051A (en) * | 1989-08-01 | 1993-05-25 | Pfizer Inc. | Thiazolyl and oxazolyl[5,4-c]piperidyl-substituted quinolone-carboxylic acid and related analogs thereof having antibacterial properties are disclosed |
| KR910009330B1 (ko) * | 1989-10-23 | 1991-11-11 | 재단법인 한국화학연구소 | 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법 |
| KR910009333B1 (ko) * | 1989-10-23 | 1991-11-11 | 재단법인 한국화학연구소 | 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법 |
| DE4121214A1 (de) * | 1991-06-27 | 1993-01-14 | Bayer Ag | 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate |
| DE4342186A1 (de) * | 1993-12-10 | 1995-06-14 | Bayer Ag | Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten |
| DE19652239A1 (de) * | 1996-12-16 | 1998-06-18 | Bayer Ag | Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen |
| US6608081B2 (en) * | 1999-08-12 | 2003-08-19 | Ortho-Mcneil Pharmaceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| US6855385B2 (en) * | 2000-05-31 | 2005-02-15 | Ttm Advanced Circuits, Inc. | PCB support plate for PCB via fill |
| EP1358185A2 (fr) * | 2001-02-07 | 2003-11-05 | Ortho-Mcneil Pharmaceutical, Inc. | Antibact riens base de pyridoarylph nyle oxazolidinone, compositions et proc d s associ s |
| MXPA05002004A (es) * | 2002-09-26 | 2005-04-28 | Pfizer | Derivados de pirazol. |
| CL2004000553A1 (es) | 2003-03-20 | 2005-02-04 | Actelion Pharmaceuticals Ltd | Uso de compuestos derivados de guanidina como antagonistas del receptor de neuropeptido ff; compuestos derivados de guanidina; procedimientos de preparacion; y composicion farmaceutica que los comprende. |
| GB0610804D0 (en) * | 2006-05-31 | 2006-07-12 | Portela & Ca Sa | New crystal forms |
| TW200823215A (en) * | 2006-08-04 | 2008-06-01 | Merz Pharma Gmbh & Amp Co Kgaa | Pyrazolopyrimidines, a process for their preparation and the use as a medicine |
| JP2011506315A (ja) * | 2007-12-05 | 2011-03-03 | バイアル−ポルテラ アンド シーエー，エス．エー． | 新たな塩、及び結晶形 |
| HRP20180483T1 (hr) * | 2011-08-31 | 2018-05-04 | Otsuka Pharmaceutical Co., Ltd. | Spoj kinolona |
| WO2019084529A1 (fr) | 2017-10-29 | 2019-05-02 | China Medical University | Inhibiteurs d'adam9 et utilisations de ceux-ci |
| WO2022171139A1 (fr) * | 2021-02-10 | 2022-08-18 | 北京国鸿生物医药科技有限公司 | Composé macrocyclique, composition pharmaceutique et leur utilisation |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE418966B (sv) * | 1974-02-18 | 1981-07-06 | Haessle Ab | Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan |
| JPS53141286A (en) * | 1977-05-16 | 1978-12-08 | Kyorin Seiyaku Kk | Novel substituted quinolinecarboxylic acid |
| JPS5746986A (en) * | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
| US4665079A (en) * | 1984-02-17 | 1987-05-12 | Warner-Lambert Company | Antibacterial agents |
| IE55898B1 (en) * | 1982-09-09 | 1991-02-14 | Warner Lambert Co | Antibacterial agents |
| JPS59128383A (ja) * | 1982-12-29 | 1984-07-24 | Kanebo Ltd | 新規キノリンカルボン酸誘導体および該化合物を有効成分とする抗菌剤 |
| JPS59204194A (ja) * | 1983-05-09 | 1984-11-19 | Hokuriku Seiyaku Co Ltd | ７−ジアザビシクロアルカン置換−６，８−ジフオロ−４−オキソ−１，４−ジヒドロキノリン−３−カルボン酸誘導体 |
| US4571396A (en) * | 1984-04-16 | 1986-02-18 | Warner-Lambert Company | Antibacterial agents |
| US4636506A (en) * | 1984-12-06 | 1987-01-13 | Pfizer, Inc. | 7-heterocyclic-1,4-dihydroquinolones |
| US4657913A (en) * | 1985-04-18 | 1987-04-14 | Warner-Lambert Company | Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents |
| DE3519286A1 (de) * | 1985-05-30 | 1986-12-04 | Bayer Ag, 5090 Leverkusen | 7-azolyl-1-cyclopropyl-1,4-dihydro-4-oxo-3- chinolincarbonsaeuren und -1,8-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| IN166416B (fr) * | 1985-09-18 | 1990-05-05 | Pfizer |
-
1987
- 1987-12-18 WO PCT/US1987/003412 patent/WO1989005643A1/fr not_active Ceased
-
1988
- 1988-12-12 IL IL88664A patent/IL88664A/xx not_active IP Right Cessation
- 1988-12-14 DE DE3852010T patent/DE3852010T2/de not_active Expired - Fee Related
- 1988-12-14 EP EP88311797A patent/EP0321191B1/fr not_active Expired - Lifetime
- 1988-12-14 MY MYPI88001451A patent/MY104072A/en unknown
- 1988-12-14 ES ES88311797T patent/ES2061695T3/es not_active Expired - Lifetime
- 1988-12-14 AT AT88311797T patent/ATE113599T1/de not_active IP Right Cessation
- 1988-12-15 ZA ZA889395A patent/ZA889395B/xx unknown
- 1988-12-15 PT PT89222A patent/PT89222B/pt not_active IP Right Cessation
- 1988-12-16 IE IE376388A patent/IE65732B1/en not_active IP Right Cessation
- 1988-12-16 AU AU26987/88A patent/AU600188B2/en not_active Ceased
- 1988-12-16 DK DK699788A patent/DK699788A/da not_active Application Discontinuation
- 1988-12-16 JP JP31934188A patent/JPH0725757B2/ja not_active Expired - Lifetime
- 1988-12-16 NZ NZ227357A patent/NZ227357A/en unknown
- 1988-12-17 KR KR1019880016841A patent/KR900008568B1/ko not_active Expired
-
1989
- 1989-08-01 US US07/435,496 patent/US5037834A/en not_active Expired - Lifetime
- 1989-08-17 FI FI893883A patent/FI90239C/fi not_active IP Right Cessation
- 1989-08-17 NO NO893305A patent/NO178149C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK699788D0 (da) | 1988-12-16 |
| EP0321191A2 (fr) | 1989-06-21 |
| JPH01211587A (ja) | 1989-08-24 |
| IE65732B1 (en) | 1995-11-15 |
| NZ227357A (en) | 1991-04-26 |
| DK699788A (da) | 1989-08-11 |
| FI90239C (fi) | 1994-01-10 |
| FI90239B (fi) | 1993-09-30 |
| NO893305L (no) | 1989-10-17 |
| PT89222B (pt) | 1994-11-30 |
| IE883763L (en) | 1989-06-18 |
| ATE113599T1 (de) | 1994-11-15 |
| AU600188B2 (en) | 1990-08-02 |
| DE3852010T2 (de) | 1995-03-09 |
| FI893883A7 (fi) | 1989-08-17 |
| FI893883A0 (fi) | 1989-08-17 |
| PT89222A (pt) | 1989-12-29 |
| US5037834A (en) | 1991-08-06 |
| WO1989005643A1 (fr) | 1989-06-29 |
| KR900008568B1 (ko) | 1990-11-24 |
| EP0321191B1 (fr) | 1994-11-02 |
| NO178149B (no) | 1995-10-23 |
| EP0321191A3 (fr) | 1991-02-27 |
| IL88664A (en) | 1993-08-18 |
| ES2061695T3 (es) | 1994-12-16 |
| AU2698788A (en) | 1989-06-22 |
| ZA889395B (en) | 1990-08-29 |
| NO893305D0 (no) | 1989-08-17 |
| JPH0725757B2 (ja) | 1995-03-22 |
| IL88664A0 (en) | 1989-07-31 |
| MY104072A (en) | 1993-11-30 |
| DE3852010D1 (de) | 1994-12-08 |
| KR890009925A (ko) | 1989-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI893883A0 (fi) | Menetelmä terapeuttisesti aktiivisten 7-tetrahydronaftyridiini-6-fluori-1,4-dihydro-4-oksokinoliini-3-karboksyylihappojen valmistamiseksi | |
| AU659444B2 (en) | Intermediates for the manufacture of 6-fluoro-1, 4-dihydro-4-oxoquinoline carboxylic acids | |
| NO904625L (no) | Fremgangsmaate for fremstilling av 1h-imidazo 4,5-c kinoliner. | |
| ES8800244A1 (es) | Un procedimiento para preparar naftiridinas antibacterianas | |
| FI883050A0 (fi) | Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi | |
| FI894477A7 (fi) | Menetelmä terapeuttisesti aktiivisten 7-substituoitujen 3,5-dihydroksihept-6-yynihappojen ja niiden johdannaisten valmistamiseksi ja välituotteina käyttökelpoiset yhdisteet | |
| OA06930A (fr) | Procédé de préparation d'acides aza-bicyclo-octane carboxyliques. | |
| NO177141C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aminosyreantagonister | |
| NO175307C (no) | Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 3,3'-ditiobis(propionsyrer) | |
| NO924690D0 (no) | Fremgangsmaate for fremstilling av mono-n-substituerte tetraazakrocykluser | |
| ES2113938T3 (es) | Isomeros opticos de 7-(3-(1,1-dialquilmetil-1-amino)-1-pirrolidinil)-quinolonas y naftiridonas utilizados como agentes antibacterianos. | |
| NO177712C (no) | Analogifremgangsmåte for fremstilling av nye terapeutisk virksomme alkylfosfonoseriner | |
| FR2692263B1 (fr) | Procédé de préparation d'esters cycliques d'acides-alpha-hydroxycarboxyliques. | |
| CS470587A2 (en) | Method of 4-hydroxypyrrolidine-2-on-1-ylacetamide production | |
| JPS5692289A (en) | Manufacture of nitrogen heterocyclic compound | |
| PT86727A (pt) | Process for preparing bicyclic beta-lactam carboxylic acids | |
| NO885200D0 (no) | Fremgangsmte for fremstilling av pro-legemidler. | |
| NO870482D0 (no) | Fremgangsmaate ved fremstilling av nye karboksylsyreamider. | |
| NO175859C (no) | Fremgangsmåte for fremstilling av kinolincarboxylsyrer | |
| HU9303505D0 (en) | Process for producing organic compound | |
| ES2048213T3 (es) | Procedimiento de preparacion de anhidridos de acidos. | |
| IT1174495B (it) | Composti ad attivita'ipolipemizzante | |
| HUP9601361A2 (hu) | Eljárás optikailag aktív vegyületek előállítására | |
| IT8722029A0 (it) | Trattamento dei sottoprodotti del procedimento di produzione di caprolattame da acido benzoico. | |
| FR2708599B1 (fr) | Procédé de fabrication d'esters halogénés d'acides carboxyliques ou dicarboxyliques. |